Remarkably, our above evidence supports a notion that EZH2 may further facilitate oncogenesis via enhancing the translation of a series of cancer regulators through its catalytic activity, with YTHDF1 playing a pivotal role in this process. The gene discussed is EZH2; the disease is cancer.